Author

Marianne Harris

Observed names: Harris, Marianne, M Harris, M. M. Harris, M.M. Harris

Institutions: Providence Health Care, University of British Columbia, AIDS Vancouver, BC Centre for Excellence in HIV/AIDS

Observed institutions: Providence Health Care, University of British Columbia, St. Paul's Hospital, AIDS Vancouver, St. Paul's Hospital, BC Centre for Excellence in HIV/AIDS, Charles R. Drew University of Medicine and Science

OpenAlex ID: A5002899083

Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database

2001 · Katherine V. Heath, Robert S. Hogg, et al. · AIDS · 249

Combination Therapy With Fenofibrate and Rosiglitazone Paradoxically Lowers Serum HDL Cholesterol

2004 · Lena Normén, Jiri Frohlich, et al. · Diabetes Care · 30

The Determinants of Poor Respiratory Health Status in Adults Living with Human Immunodeficiency Virus Infection

2014 · Janice M. Leung, Joseph C. Liu, et al. · AIDS Patient Care and STDs · 25

Use of metabolic drugs and fish oil in HIV‐positive patients with metabolic complications and associations with dyslipidaemia and treatment targets

2007 · L Normén, B Yip, et al. · HIV Medicine · 12

Prevalence and Correlates of Frailty Among Older Adults Living With HIV in the CHANGE HIV Cohort

2024 · Alice Zhabokritsky, Marina Klein, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 11

Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada

2022 · Katherine J. Lepik, Lu Wang, et al. · AIDS · 4

Case series: Symptom‐inhibited fentanyl induction (SIFI) onto treatment‐dose opioid agonist therapy in a community setting

2025 · Pouya Azar, Jane J. Kim, et al. · American Journal on Addictions · 3

Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada

2024 · Katherine J Lepik, Olivia L Hunt, et al. · Antiviral Therapy · 3

Beyond direct-acting antiviral therapy: Characterizing mental health conditions and depressive symptoms among patients recently treated for hepatitis C

2026 · Sarah E. Kelly, Adedayo Ajidahun, et al. · PLoS ONE · 1

Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site

2025 · Alannah Hannigan, Nandini Krishnan, et al. · BMC Health Services Research · 1

Symptom-inhibited fentanyl induction (SIFI) for hospitalized patients with opioid use disorder: a retrospective chart review

2026 · Victor W. Li, James S. H. Wong, et al. · Addiction Science & Clinical Practice

Vascular risk drives cognitive decline over 10 years in people aging with well controlled HIV

2026 · Marie-Josée Brouillette, Susan C. Scott, et al. · AIDS

Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV

2026 · Sofia Nicolls, Elisabeth McClymont, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes

Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial

2025 · Pouya Azar, Martha J. Ignaszewski, et al. · Addiction Science & Clinical Practice

153 Comparative Non-high-density Lipoprotein Cholesterol Lowering Between Gemfibrozil and Statins in Diabetes Mellitus.

2006 · S. H. Hsia, M. M. Harris, et al. · Journal of Investigative Medicine

Comparative Non-High-Density Lipoprotein Cholesterol Lowering between Gemfibrozil and Statins in Diabetes Mellitus

2006 · S.H. Hsia, M.M. Harris, et al. · Journal of Investigative Medicine

Works count: 18

Citation count: 339

H-index: 5

I10-index: 5